President Cyril Ramaphosa and Health Minister Aaron Motsoaledi launch Lenacapavir, a twice-yearly injectable HIV prevention option, during a rollout event in Mpumalanga.
South Africa has officially launched the rollout of a new twice-yearly HIV prevention injection, Lenacapavir, in what President Cyril Ramaphosa described as a major turning point in the country’s long fight against HIV and AIDS.
South Africa has launched the rollout of a new twice-yearly HIV prevention injection, Lenacapavir, in what Ramaphosa described as a “major turning point” in the country’s long and ongoing fight against HIV and AIDS.
The launch took place in Secunda, Mpumalanga, on Friday, where Ramaphosa officially introduced the programme as part of a strengthened national prevention strategy aimed at reducing new HIV infections and expanding access to innovative biomedical tools.
Ramaphosa said the introduction of Lenacapavir represents a significant scientific breakthrough in HIV prevention and a milestone in South Africa’s public health response.
